bioRxiv/medRxiv TRiP Review Activity

428 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 25: Articles 241-250  | Next

β-catenin activity induces an RNA biosynthesis program promoting therapy resistance in T Acute Lymphoblastic Leukemia
Garcia-Hernandez, V., Arambilet, D., Guillen, Y., Lobo, T., Gekas, C., Vega-Garcia, N., Sentis, I., Trincado, J. L., Marquez-Lopez, I., Heyn, H., Camos, M., Espinosa, L., Bigas, A.
10.1101/2022.07.07.499249 — Posted: 2022-07-09 — Discussion: 2023-04-27  EMBO Press
An RNA-binding switch drives ribosome biogenesis and tumorigenesis downstream of RAS oncogene
Azman, M. S., Dodel, M., Capraro, F., Faraway, R., Dermit, M., Fan, W., Ule, J., Mardakheh, F. K.
10.1101/2021.12.16.472890 — Posted: 2021-12-16 — Discussion: 2023-04-25  EMBO Press
Comprehensive characterization of tumor microenvironment in colorectal cancer via histopathology-molecular analysis
Wu, X., Yan, H., Qiu, M., Qu, X., Wang, J., Xu, S., Zheng, Y., Ge, M., Yan, L., Liang, L.
10.1101/2023.02.16.528849 — Posted: 2023-02-20 — Discussion: 2023-04-23  eLife
Inhibitors of ROCK kinases induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells
Martino, J., Siri, S. O., Paviolo, N. S., Garro, C., Pansa, M. F., Carbajosa, S., Brown, A., Bocco, J. L., Gloger, I., Drewes, G., Madauss, K. P., Soria, G., Gottifredi, V.
10.1101/2022.06.24.497514 — Posted: 2022-06-28 — Discussion: 2023-04-20  eLife
FOXP2 confers oncogenic effects in prostate cancer through activating MET signalling
Zhu, X., Chen, C., Wei, D., Xu, Y., Liang, S., Jia, W., Li, J., Qu, Y., Zhai, J., Zhang, Y., Wu, P., Hao, Q., Zhang, L., Zhang, W., Yang, X., Pan, L., Qi, R., Li, Y., Wang, F., Yi, R., Yang, Z., Wang, J., Zhao, Y.
10.1101/2022.07.06.498943 — Posted: 2022-07-06 — Discussion: 2023-04-06  eLife
Proteomics Characteristics Reveal the Risk of T1 Colorectal Cancer Metastasis to Lymph Nodes
Zhuang, A., Zhuang, A., Qin, Z., Zhu, D., Ren, L., Wei, Y., Zhou, P., Yue, X., He, F., Xu, J., Ding, C.
10.1101/2022.09.22.508997 — Posted: 2022-09-23 — Discussion: 2023-04-01  eLife
Mesenchymal stem cell models reveal critical role of Myc as early molecular event in osteosarcomagenesis
Akkawi, R., Monin, J., Diment, J., Stein, G. S., Aqeilan, R. I.
10.1101/2023.03.14.532523 — Posted: 2023-03-15 — Discussion: 2023-03-27  Review Commons
High-grade serous ovarian carcinoma organoids as models of chromosomal instability
Vias, M., Morrill Gavarro, L., Sauer, C. M., Sanders, D., Piskorz, A. M., Couturier, D.-L., Ballereau, S., Hernando, B., Hall, J., Correia-Martins, F., Markowetz, F., Macintyre, G., Brenton, J. D.
10.1101/2022.09.01.506155 — Posted: 2022-09-02 — Discussion: 2023-03-16  eLife
Uveal Melanoma: a miR-16 disease?
Quemener, A. M., Bachelot, L., Aubry, M., Avner, S., Leclerc, D., Salbert, G., Cabillic, F., Decaudin, D., Mari, B., Mouriaux, F., Galibert, M.-D., Gilot, D.
10.1101/2021.11.30.470499 — Posted: 2021-12-01 — Discussion: 2023-03-15  EMBO Press
The eukaryotic translation initiation factor eIF4E reprogrammes the splicing machinery anddrives alternative splicing
Ghram, M., Morris, G., Culjkovic-Kraljacic, B., Gendron, P., Skrabanek, L., Revuelta, M. V., Cerchietti, L., Guzman, M., Borden, K.
10.1101/2021.12.07.471666 — Posted: 2021-12-09 — Discussion: 2023-03-15  EMBO Press

Evaluation Sources